Johnson & Johnson Is Great. Here's Why You Shouldn't Buy It.
Johnson & Johnson (NYSE: JNJ) is an iconic U.S. healthcare giant. It has changed over the years, but today its focus is on pharmaceuticals and medical devices. And it is an industry leader in both spaces. There are a lot of positives with J&J, as it is more commonly known on Wall Street, but there's one dark cloud that I can't ignore. And the shadow from that cloud is why I just can't justify buying Johnson & Johnson today.When I look for stocks, I generally start with the dividend. And I don't look at the yield, instead focusing on the dividend growth streak. The longer a company has increased its dividend, the better, since only financially strong and well-run companies can hike the dividend year in and year out. J&J's streak is a huge 63 years, making it a Dividend King. I own a lot of Dividend Kings because I believe it is a clear indication that a business is well run.Image source: Getty Images.Continue reading
Johnson & Johnson (NYSE: JNJ) is an iconic U.S. healthcare giant. It has changed over the years, but today its focus is on pharmaceuticals and medical devices. And it is an industry leader in both spaces. There are a lot of positives with J&J, as it is more commonly known on Wall Street, but there's one dark cloud that I can't ignore. And the shadow from that cloud is why I just can't justify buying Johnson & Johnson today.
When I look for stocks, I generally start with the dividend. And I don't look at the yield, instead focusing on the dividend growth streak. The longer a company has increased its dividend, the better, since only financially strong and well-run companies can hike the dividend year in and year out. J&J's streak is a huge 63 years, making it a Dividend King. I own a lot of Dividend Kings because I believe it is a clear indication that a business is well run.
Image source: Getty Images.
